The anti‐TLR4 monoclonal antibody Sa15‐21 enhances inflammatory cytokine production in LPS‐stimulated macrophages
The anti‐TLR4 monoclonal antibody Sa15‐21 enhances inflammatory cytokine production in LPS‐stimulated macrophages
复制标题
抗 TLR4 单克隆抗体 Sa15-21 增强 LPS 刺激的巨噬细胞中炎症细胞因子的产生
DOI:
10.1002/1873-3468.14619
复制
发表时间:
2023
期刊:
影响因子:
3.5
通讯作者:
Akashi‐Takamura Sachiko
中科院分区:
文献类型:
--
作者:
Chowdhury Sajid Iftekhar;Inui Masanori;Yamazaki Tatsuya;Tomono Susumu;Takagi Hidekazu;Biswas Mrityunjoy;Saitoh Shin‐Ichiroh;Miyake Kensuke;Akashi‐Takamura Sachiko
Sa15‐21, a monoclonal antibody against mouse Toll‐like receptor (TLR) 4, can protect mice from lipopolysaccharide (LPS)/D‐galactosamine‐induced acute lethal hepatitis. Herein, we investigated the molecular mechanisms underlying Sa15‐21‐mediated regulation of TLR4 signaling in macrophages. Results showed that Sa15‐21 enhanced the production of proinflammatory cytokines and attenuated the production of anti‐inflammatory cytokines in LPS‐stimulated macrophages. Western blotting analysis revealed that Sa15‐21 pretreatment had no effect on NF‐κB and MAPK signaling in LPS‐stimulated macrophages; however, Sa15‐21 treatment alone led to a weak and delayed activation of NF‐κB and MAPK signaling without any effect on proinflammatory cytokine production. By contrast, Sa15‐21 failed to induce the activation of interferon regulatory factor 3. Taken together, our results indicate that Sa15‐21 sensitizes macrophages to facilitate the inflammatory response via TLR signaling.